Description
Blinatumomab: new hope for patients with relapsed/refractory acute lymphoblastic leukemia
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: Blinatumomab: new hope for patients with relapsed/refractory acute lymphoblastic leukemia
€3.03
Related products
-
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart -
Article: Highlights in melanoma
€3.03 Add to cart -
Article: Highlights in urologic cancer
€3.03 Add to cart
Reviews
There are no reviews yet.